Ella (Ulipristal Acetate) - Current Clinical Trials

Ella Related Clinical Trials

SX ELLA Esophageal Degradable BD Stent System [Recruiting]

CDB-2914 for Abnormal Uterine Bleeding in Premenopausal Women [Not yet recruiting]

Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914 [Recruiting]

Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women [Recruiting]

Biodegradable Stents in Lung Transplantation [Recruiting]

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata [Recruiting]

Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne� or Placebo. [Recruiting]

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata [Recruiting]

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) [Recruiting]

Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer [Recruiting]

A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids [Recruiting]

Perioperative Hyperglycaemia in Primary Total Hip and Knee Replacement [Recruiting]

Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer [Recruiting]

Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab [Recruiting]

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Recruiting]